Pragati Bodkhe
Genomic Biomarkers are biological molecules found in blood, other body fluids, or tissues that are a sign of a normal or abnormal process, or of a condition or disease. Genomic biomarkers have gained popularity in cancer diagnosis and management by providing information on disease prognosis, therapeutic responses, and disease recurrence. The demand for genomic biomarkers in cancer detection and management is driven by various factors including growing cancer burden, increasing adoption of personalized medicines, and rising applications of companion diagnostics.
The Global Genomic Biomarker Market Is Estimated To Be Valued At US$ 4,396.6 Mn In 2021, And Is Expected To Exhibit A CAGR Of 9.5% Over The Forecast Period (2021-2028).
The Genomic Biomarker Market Demand is growing significantly driven by rising cancer incidence globally. As per WHO, cancer burden is expected to rise by 50% to 15 million new cases by 2040. This growing disease prevalence is propelling the adoption of genomic biomarkers for early detection and prognostic monitoring of cancer.
Get More Insights On-Genomic Biomarker Market
This post was created with our nice and easy submission form. Create your post!
